PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-16.40%
Revenue decline while MCHP shows 12.02% growth. Joel Greenblatt would examine competitive position erosion.
-4.26%
Cost reduction while MCHP shows 9.30% growth. Joel Greenblatt would examine competitive advantage.
-29.55%
Gross profit decline while MCHP shows 14.42% growth. Joel Greenblatt would examine competitive position.
-15.72%
Margin decline while MCHP shows 2.14% expansion. Joel Greenblatt would examine competitive position.
1.13%
R&D growth less than half of MCHP's 18.71%. David Dodd would verify if efficiency advantage is sustainable.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.70%
Operating expenses reduction while MCHP shows 11.20% growth. Joel Greenblatt would examine advantage.
-4.76%
Total costs reduction while MCHP shows 9.94% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
247.08%
D&A growth above 1.5x MCHP's 9.22%. Michael Burry would check for excessive investment.
88.10%
EBITDA growth exceeding 1.5x MCHP's 22.63%. David Dodd would verify competitive advantages.
125.00%
EBITDA margin growth exceeding 1.5x MCHP's 9.47%. David Dodd would verify competitive advantages.
-62.46%
Operating income decline while MCHP shows 17.07% growth. Joel Greenblatt would examine position.
-55.09%
Operating margin decline while MCHP shows 4.51% growth. Joel Greenblatt would examine position.
-64.59%
Other expenses reduction while MCHP shows 1047.04% growth. Joel Greenblatt would examine advantage.
-63.09%
Pre-tax income decline while MCHP shows 20.58% growth. Joel Greenblatt would examine position.
-55.85%
Pre-tax margin decline while MCHP shows 7.64% growth. Joel Greenblatt would examine position.
-56.10%
Tax expense reduction while MCHP shows 20.57% growth. Joel Greenblatt would examine advantage.
-63.67%
Net income decline while MCHP shows 20.58% growth. Joel Greenblatt would examine position.
-56.54%
Net margin decline while MCHP shows 7.64% growth. Joel Greenblatt would examine position.
-65.79%
EPS decline while MCHP shows 27.76% growth. Joel Greenblatt would examine position.
-64.86%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
2.06%
Share count reduction exceeding 1.5x MCHP's 8.04%. David Dodd would verify capital allocation.
-12.19%
Diluted share reduction while MCHP shows 15.77% change. Joel Greenblatt would examine strategy.